“Practice-Changing” Results Seen for Pembrolizumab in Adjuvant Setting in Renal Cell Carcinoma

June 7th 2021, 12:46am


The study's lead author said researchers have searched for a generation for an effective therapy to give to high-risk patients with renal cell carcinoma after initial surgery for the tumor.

At 5 Years, Over 30% of Patients in PACIFIC Had Stable NSCLC, Data Show

June 6th 2021, 5:52pm


Also, phase 2 results for atezolizumab presented during the 2021 Annual Meeting of the American Society of Clinical Oncology could help patients in same setting who need another option.

Preventing Respiratory Illness and Death Through Tighter Air Quality Standards

June 1st 2021, 9:13pm


On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.

After PD-1 Inhibitor Indications Are Withdrawn in SCLC, What Now?

May 26th 2021, 6:43pm


Martin J. Edelman, MD, chair of the Department of Hematology/Oncology and associate director for Translational Research at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the the nuances of rescinded indications in small-cell lung cancer.

Precision Medicine Wrap-up: Combination Therapies in CLL

May 25th 2021, 9:09pm


Recent coverage from Targeted Oncology® highlights how combination therapies are impacting the treatment spectrum for chronic lymphocytic leukemia (CLL).

New Partnerships Bring New Opportunities, Challenges With Data in HEOR

May 20th 2021, 1:10pm


Technological innovation is helping to reinvent the traditional health economics and outcomes research (HEOR) field as traditional and new players partner to leverage data sources.

What Can Be Done to Ensure Access to Care for Dual-Eligible Beneficiaries?

May 19th 2021, 3:10pm


An author of a study in the May 2021 issue of The American Journal of Managed Care® describes how the COVID-19 pandemic, the aging of America, and already-existing workforce shortages will further threaten the dual-eligible population unless policy makers reform scope-of-practice laws.

Building a More Resilient and Sustainable Health System

May 17th 2021, 9:10pm


The COVID-19 pandemic brought together the world and taught health systems how to be resilient and adapt to both predictable and unpredictable changes, said the panelists during the plenary on day 1 of Virtual ISPOR 2021.

With No End in Sight on Omega-3 Debate, Nissen Calls for More Trials

May 16th 2021, 7:57pm


Two top cardiologists debated evidence involving one clinical trial for omega-3 fatty acids, with implications for another, the REDUCE-IT study for icosapent ethyl (Vascepa).

Dapagliflozin Misses Early Mark in COVID-19, but Kosiborod Sees Reasons for More Study

May 16th 2021, 12:00pm


The Dapagliflozin in Respiratory Failure in Patients With COVID-19 trial is the first phase 3 study to examine whether this SGLT2 inhibitor, which has proven effective for multiple chronic conditions, might be similarly useful in an acute setting.